-
Mashup Score: 8Assessing the utility of molecular diagnostic classification for cancers of unknown primary - 7 month(s) ago
Cancer Medicine is an open access, broad-scope oncology journal covering clinical cancer research, cancer biology, cancer prevention, & bioinformatics.
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 11 month(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb88Zl & https://t.co/6vxGpOv5PJ #PrecisionMedicine #CUPsm @TempusLabs
-
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 11 month(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb8GOT & https://t.co/6vxGpOvDFh #PrecisionMedicine #CUPsm @TempusLabs
-
-
Mashup Score: 1Program Guide – ASCO Meeting Program Guide - 12 month(s) ago
AuthorsZachary RiversTempus Labs, Inc.Zachary Rivers, Ryan Huey, Rotem Ben-Shachar, Anjali Avadhani, Timothy Taxter, Kyle Beauchamp, Adam Hockenberry, Halla Nimeiri, Joelle Allam, Aparna Kalyan, Kanwal Raghav, Michael LeeOrganizationsTempus Labs, Inc., University of Texas MD Anderson Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, MD Anderson Cancer…
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular diagnostic classification for cancers of unknown primary (CUP): Post-testing diagnosis & tx impact analysis from real-world claims data [2023] @RiversPharmD et al. @TempusLabs @MDAndersonNews @LurieCancer #ASCO23 Abst 6610, Poster 102 https://t.co/j3dP7uplwH #CUPsm
-
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 1 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb88Zl & https://t.co/6vxGpOv5PJ #PrecisionMedicine #CUPsm @TempusLabs
-
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 1 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb88Zl & https://t.co/6vxGpOv5PJ #PrecisionMedicine #CUPsm @TempusLabs
-
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 2 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb8GOT & https://t.co/6vxGpOvDFh #PrecisionMedicine #CUPsm @TempusLabs
-
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 2 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb8GOT & https://t.co/6vxGpOvDFh #PrecisionMedicine #CUPsm @TempusLabs
-
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 2 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet-
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb88Zl & https://t.co/6vxGpOv5PJ #PrecisionMedicine #CUPsm @TempusLabs
-
-
Mashup Score: 0Cancer of Unknown Primary Site | NEJM - 2 year(s) ago
Review Article from The New England Journal of Medicine — Cancer of Unknown Primary Site
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Cancer of Unknown Primary Site [2014] Varadhachary & Raber @NEJM https://t.co/qpHAvv4ntF #CUPsm
-
Assessing the utility of molecular diagnostic classification for cancers of unknown primary (CUP) [Sep 15, 2023] Moore et al. Cancer Medicine https://t.co/Bi4DV9ro2u #CUPsm #PrecisionMedicine #openaccess https://t.co/yBpZsNsg4F